MRI-Based Quantification of Intratumoral Heterogeneity for Predicting Progression-Free Survival in Patients with Lung Cancer Brain Metastasis Receiving Radiotherapy

A habitat risk model based on intratumoral heterogeneity could be a reliable biomarker for predicting PFS in patients with LCBM receiving radiotherapy.